• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards

FogPharma

rollercoaster ride theme park scary crazy
Biotech

Parabilis ups planned IPO haul to record-setting $637M

Once known as FogPharma, Parabilis plans to offer 33,333,334 shares of common stock priced between $17 and $19 apiece.
Darren Incorvaia Jun 9, 2026 10:22am
Space rocket moon explore

Tumor-focused Parabilis raises $305M to 'upend status quo'

Jan 8, 2026 7:00am
fog mountains sunbeam glow morning trees hills sky

FogPharma clears $145M series E thanks to Borisy, ex-J&J CEO  

Mar 1, 2024 9:55am
parachute sunset paragliding chutes

BMS CEO set to leave after 8-year run—Chutes & Ladders

Apr 28, 2023 9:30am
chutes sunset mountain parachute

Ex-J&J research chief lands at FogPharma—Chutes & Ladders

Mar 31, 2023 9:30am
spooky ghost

Former J&J R&D chief Mathai Mammen lands at FogPharma

Mar 30, 2023 6:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings